
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MKP-1/DUSP1 CRISPR/Cas9 KO Plasmid (m) | sc-422507 | 20 µg | $397.00 |
Dual specificity phosphatase 1 (Dusp1), also known as MKP-1/DUSP1, is an inducible MAPK phosphatase that dephosphorylates and inactivates ERK1/2, JNK, and p38 MAPKs to constrain signal duration after stress, cytokine, and growth factor stimulation. In mouse cells, DUSP1 functions as a key feedback regulator linking MAPK activity to transcriptional programs governing inflammation, apoptosis, differentiation, and adaptation to oxidative and genotoxic stress. Through modulation of MAPK-dependent transcription factors and downstream cytokine outputs, DUSP1 influences innate immune signaling and cellular stress responses. Dysregulated DUSP1 expression or activity has been associated with altered inflammatory phenotypes and aberrant MAPK signaling in contexts including metabolic and oncogenic stress, supporting its use as a mechanistic node for pathway interrogation.
MKP-1/DUSP1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Dusp1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Dusp1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Dusp1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MKP-1/DUSP1 protein expression.
This CRISPR knockout system enables efficient generation of Dusp1-deficient cell models for investigation of MKP-1/DUSP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.